How profitable is National Health Investors Inc. (NHI)?

In FY 2025 (10-K), NHI converted $80.1M of revenue into a 52% gross margin, 0% operating margin, and $0 in free cash flow (0% FCF margin).

Stock Ratings / Financials / NHI / financials

BNL (55) HIW (65) IRT (46) SLG (59) ⌘ Pro Terminal →

National Health Investors Inc. (NHI) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

$68.77 +0.39% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $68.69

National Health Investors Inc. (NHI) carries a Roarable Rating of D- (Sell) with 43/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- • SELL / AVOID Cap $3.36B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on NHI Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is NHI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, National Health Investors Inc. (NYSE: NHI) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 43/100 at a spot price of $68.77 (+0.39% 1D, market cap $3.36B). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 6/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 8/20. Across 1097 tracked Financials issuers, NHI ranks #842 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does NHI compare to BNL and HIW in the Financials sector?

▼

Within the Financials sector (Real Estate Investment Trusts), NHI carries a Roarable D- (43/100 RQD), trailing P/E of 23.1x, gross margin of —, and ROIC of 9.3%. By comparison, BNL (Broadstone Net Lease Inc.) holds a D+ grade (55/100 RQD, P/E 34.6x, ROIC 2.3%, cap $3.38B) and HIW (Highwoods Properties Inc.) posts a C grade (65/100 RQD, P/E N/A, ROIC 18.3%, cap $3.45B). Among the 5-stock peer group, NHI leads on earnings multiple (23.1x) while HIW leads on capital efficiency (18.3% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for NHI?

▼

Per NHI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000877860), National Health Investors Inc. generated $80.1M in revenue (+47.1% YoY), $142.2M in net income, and -$57.5M in free cash flow against $2.80B in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $68.69 (-0.12%)🧬 Disciplined Float (+1.08% YoY Shares)⚙️ Cash Engine: 8/20 (D-) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (43/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-6.7% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D-

2-of-3 Quant Analysts Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR RQD RADARRw D- · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-6.7% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for NHI)Realized 20D OHLCV Swing Band: ±4.2%

Deterministic 5-Pillar Attribution (43/100 Composite)

🔍 WHY NHI SCORES 43/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (30% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 5/9

▲ #2 Bullish Driver: Cash Engine Quality+8/20 pts (19% of score)

SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 52% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning6/20 pts (-14 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-14 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$65.36-0.7% Next Q

Q2 (-2Q)

Grade E$64.92+1.2% Next Q

Q3 (-1Q)

Grade D$65.68+4.7% Next Q

Current

Grade D-$68.77-6.7% Hist 90D α

Trajectory: E (35) → D- (43)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a NHI Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While NHI currently carries a cautious 43/100 (D-) rating due to Whale & Options Positioning (6/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Financials with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($67.75) and Max Pain ($72.21) forces dealer call-delta covering toward $95.95.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+1.08% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $NHI• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “NHI Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 43%NO 57%Trade / Inspect Odds →

VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL • FY 2025 (10-K)

How NHI Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$0 (0% FCF Margin)

Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory

■ Revenue■ Net Profit■ Free Cash Flow

FY23

Rev $48.8M

FY24

Rev $54.4M

FY25

Rev $80.1M

Fiscal Year	Revenue	Gross Margin	Op Margin	Net Profit	Free Cash Flow	ROIC %
FY 2025	$80.1M	52%	0%	$142.2M	-$57.5M	9.3%
FY 2024	$54.4M	52%	0%	$138.0M	$49.8M	9.3%
FY 2023	$48.8M	52%	0%	$135.7M	$184.4M	9.3%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring NHI)

✓Walkthrough of NHI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

NHI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -5.91%📐 HORIZONTAL RANGE

2026-11-04O $67.04H $68.77L $67.04C $68.77VOL 296.3K

RES: $88.09SUP: $60.74SMA50: $67.75SMA200: $76.19

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

NHI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 NHI Butterfly Map → + Track NHI →

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle

16.9%/yr Implied 5Y Growth

vs. +47.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on NHI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for NHI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for NHI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (NHI)

Financials Rank #842 of 1097 ⚔️ BNL vs NHI Full Matrix →

1. Head-to-Head Financials Peer Comparison (NHI vs. BNL, HIW, IRT, SLG)

Industry: Real Estate Investment Trusts (172 Tracked Issuers)

Across 1097 tracked Financials securities in the Roarable RQD universe, National Health Investors Inc. (NHI) ranks #842 by composite RQD confidence (43/100, grade D-) and #342 by equity capitalization ($3.36B). Within this direct 5-issuer industry benchmark cohort, NHI leads on earnings valuation at 23.1x trailing P/E, while HIW leads on capital efficiency and profitability with 18.3% ROIC and — gross margin. HIW currently holds the highest overall quantitative score in the immediate peer group at 65/100 (C) compared with NHI at 43/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
NHI ACTIVE National Health Investors Inc.	D-	43/100	23.1x	—	9.3%	+0.39%	$3.36B	Benchmark Subject
BNL Broadstone Net Lease Inc.	D+	55/100	34.6x	—	2.3%	+2.22%	$3.38B	/bnl-vs-nhi →
HIW Highwoods Properties Inc.	C	65/100	—	—	18.3%	-1.60%	$3.45B	/hiw-vs-nhi →
IRT Independence Realty Trust Inc.	D	46/100	61.7x	—	1.6%	-0.87%	$3.52B	/irt-vs-nhi →
SLG SL Green Realty Corp	C-	59/100	—	—	14.7%	-2.16%	$3.58B	/slg-vs-nhi →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000877860 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), National Health Investors Inc. (NHI) reported GAAP revenue of $80.1M (+47.1% vs. FY2024 revenue of $54.4M , and +64.0% cumulative change since FY2023) , GAAP net income of $142.2M, operating cash flow of $236.6M, and free cash flow of -$57.5M (-215.3% YoY). On the balance sheet, NHI closed FY2025 with $2.80B in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 5/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$80.1M	$142.2M	$236.6M	-$57.5M	$2.80B	—
FY2024 (FY)	2024-12-31	$54.4M	$138.0M	$207.8M	$49.8M	$2.61B	—
FY2023 (FY)	2023-12-31	$48.8M	$135.7M	$184.4M	$184.4M	—	—

3. NHI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is NHI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does NHI compare to BNL and HIW in the Financials sector?

What are the biggest fundamental strengths and SEC risk factors for NHI?

Where is NHI trading relative to its 50-day, 200-day, and 52-week technical levels?

NHI last traded at $68.77 (+0.39% on volume of 330,199 shares), positioning the stock +1.51% above its 50-day simple moving average ($67.75) and -9.74% below its 200-day simple moving average ($76.19). Across its 52-week range of $63.51 to $91.38, NHI sits at the 18.9% percentile with a 14-day RSI of 58.6 (BULLISH MOMENTUM) and an implied next-earnings move of ±4.2% ($65.88 to $71.66).

Direct Sub-Reports: NHI RQD Cockpit NHI 12M Forecast NHI Earnings & Move NHI Dividends & DRIP NHI Insiders & 13F NHI Whale Options NHI Profit Sankey NHI News & Why

ROARABLE RATING BRIEF • RQD 43/100 (D-) ✓ SEC XBRL & RQD VERIFIED

NHI — National Health Investors Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit

Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

National Health Investors Inc. (NHI) earns a live Roarable RQD composite score of 43/100, corresponding to a D- letter grade (Roarable Sell) at a spot price of $68.77 (+0.39% 1D, market capitalization $3.36B).

Fundamental Cash Engine (8/20): Anchored by return on invested capital (ROIC) of 9.3%, gross margin of —, operating margin of —, and free cash flow yield of -1.75%.
Whale 13F & Options Flow (6/20) + Insider Conviction (8/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
Macro Regime Fit (8/20) + Forensic Balance Sheet (13/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 5/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

National Health Investors Inc. (NHI) is a NYSE-listed issuer classified in the Financials sector and the Real Estate Investment Trusts industry,. Market capitalization is $3.3B.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), National Health Investors Inc. (NHI) reported $80.1M in annual revenue (up from $54.4M in FY2024, +47.1% YoY) and $142.2M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($48.8M revenue, $135.7M net income) through FY2025, NHI scaled operating cash flow to $236.6M and free cash flow to -$57.5M, backed by $2.80B in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

🐂 Primary Bull Case (D- • RQD 43/100): Established market leader in Financials with deep daily trading liquidity. Free cash flow yield of -1.75% and institutional whale pillar of 6/20. With Fundamental Cash Engine at 8/20 and Institutional Whale Flow at 6/20, sustained execution supports upside toward the upper end of the $63.51 – $91.38 52-week range.
🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh 23.1x trailing P/E against — operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Supply_chain is NONE, butterfly_links is empty, and proprietary_signals is empty. No upstream or downstream dependencies, sector correlations, or second-order bottlenecks are identified in the source data. Investors should note that the absence of mapped links is itself a data limitation rather than evidence of independence.

Key Question #1: Can NHI sustain or expand its — operating margin and 9.3% ROIC against Real Estate Investment Trusts peers over the next 4 quarters?
Key Question #2: Following FY2025 revenue of $80.1M and free cash flow of -$57.5M, how will capital allocation balance growth reinvestment against $0 in total debt?
Key Question #3: How sensitive is NHI's 19.4x forward P/E multiple to Financials capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

NHI Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for National Health Investors Inc. (NHI) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to NHI Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo Finance • 2d ago

National Health Investors, Inc. (NHI) Stock Forecasts

Yahoo Finance report covering National Health Investors Inc. (NHI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Seeking Alpha • 2d ago

National Health Investors: This 5.7% Healthcare REIT Is A Hold (NYSE:NHI)

Seeking Alpha report covering National Health Investors Inc. (NHI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH Seeking Alpha • 2d ago

National Health Investors: Down 28% Since February, But Bear Case Now Looks Weak

Seeking Alpha report covering National Health Investors Inc. (NHI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 2d ago

DRH or NHI: Which Is the Better Value Stock Right Now?

Yahoo Finance report covering National Health Investors Inc. (NHI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Simply Wall St • 2d ago

National Health Investors (NYSE:NHI) Stock Price

Simply Wall St report covering National Health Investors Inc. (NHI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE MarketBeat • 2d ago

111,027 National Health Investors, Inc. $NHI Shares Sold by Sound Income Strategies LLC

MarketBeat report covering National Health Investors Inc. (NHI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE TradingKey • 2d ago

National Health Investors Inc (NHI) Technical Analysis: Support, Resistance, Indicators & Moving Averages

TradingKey report covering National Health Investors Inc. (NHI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE https://www.dars.gov.et/ • 2d ago

National Health Investors (NHI) Slides 2.41% to $63.96 as Shares Drift Toward Key Support - Beta Neutral Pair

https://www.dars.gov.et/ report covering National Health Investors Inc. (NHI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

NHI Bull vs. Bear Conversation Board — What's Your Call at $68.77?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON NHI 🐻 33% BEARISH CONVICTION

DE DeltaGamma_99 RQD DEBATE OPENER • Options Flow Specialist 🐂 BULLISH 🎯 Target: $88.49 (+32.0%)

📌 Pinned Debate

Forensic balance sheet scores 13/20 with Altman Z 2.5, Piotroski F 5/9 and Debt/Equity 0.5, and the stock carries a 5.16% dividend yiel

Long NHI at $67.04 targeting $88.49. Forensic balance sheet scores 13/20 with Altman Z 2.5, Piotroski F 5/9 and Debt/Equity 0.5, and the stock carries a 5.16% dividend yield with a forward P/E of 19.4 below its trailing 23.1.. Institutional whale score is 6/20 and the risk/reward vs. the $63.51 52-week low is skewed heavily in favor of bulls.

ArenaChamp_24 🐂 BULL

@DeltaGamma_99 Agree on the RQD 43/100 quality, though with 1.0 beta I'm scaling in with half-size at $67.04 and keeping dry powder in case we test $62.35.

FA FadeTheHype RQD DEBATE OPENER • Contrarian Tape Reader 🐻 BEARISH 🎯 Target: $56.31 (-16.0%)

Spot @ $67.04

Free cash flow fell from $184.4M in FY 2023 to -$57.5M in FY 2025, FCF yield is -1.75%, and institutional flow scores only 6/20 per the

Here is the bear case nobody on the bull side wants to address on NHI: Free cash flow fell from $184.4M in FY 2023 to -$57.5M in FY 2025, FCF yield is -1.75%, and institutional flow scores only 6/20 per the RQD rating.. At 23.1x trailing P/E, even a small guidance miss in Real Estate Investment Trusts triggers a 12-15% air pocket.